2057 |
ERYTHROPOIETIN RECEPTOR |
EPOR |
EPO-R |
133171 |
3416 |
ENSG00000187266 |
OTTHUMG00000182027 |
P19235 |
EPOR_HUMAN |
T65197 |
1728 |
Target Class | Receptors |
Target Subclass | Receptor |
Target Subclass | Type 1 cytokine receptor |
Target Subclass | IG |
Transmembrane Helix Count | 1 |
Target Main Class | Receptors |
Target Subclass | CytokineR |
Target Subclass | Type1 |
Gene Biotype | PROTEIN_CODING |
KINASE |
EXTERNAL SIDE OF PLASMA MEMBRANE |
DRUGGABLE GENOME |
CLINICALLY ACTIONABLE |
TRANSCRIPTION FACTOR |
agonist (activating) |
stimulator (activating) |
Novel drug target | Established target |
Trial Name | Hematide |
Mechanism of Interaction | Erythropoietin receptor agonist |
agonist (activating) |
Mechanism of Interaction | Erythropoietin receptor agonist |
Direct Interaction | yes |
agonist (activating) |
agonist (activating) |
Mechanism of Interaction | Erythropoietin receptor agonist |
Direct Interaction | yes |
agonist (activating) |
Trial Name | epoetin alpha |
Novel drug target | Established target |
Trial Name | epoetin delta, gene-activated erythropoietin,Dynepo |
agonist (activating) |
Mechanism of Interaction | Erythropoietin receptor agonist |
Direct Interaction | yes |
EPOR | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
EPOR_HUMAN | Uniprot Id |
ENSG00000187266 | Ensembl Gene Id |
P19235 | Uniprot Accession |
Target Subclass | IG |
Transmembrane Helix Count | 1 |
Target Main Class | Receptors |
EPOR | Gene Symbol |
Target Class | Receptors |
Target Subclass | Receptor |
Target Subclass | Type 1 cytokine receptor |
2057 | Entrez Gene ID |
1728 | CIViC Gene ID |
EPOR | GENE_SYMBOL |
Erythropoietin receptor | UNIPROT |
EPO-R | UNIPROT |
ENSG00000187266 | Gene Symbol |
EPOR | Ensembl Id |
DRUGGABLE GENOME |
EPOR | Gene Symbol |
CLINICALLY ACTIONABLE |
EPOR | TTD Gene Abbreviation |
T65197 | TTD Target ID |
Erythropoietin receptor | Gene Name |
P19235 | UniProt ID |
KINASE, TRANSCRIPTION FACTOR |
CLINICALLY ACTIONABLE |
EXTERNAL SIDE OF PLASMA MEMBRANE |